(Q45888529)

English

Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancy

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancy (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

0 references

0 references

author name string

Engel BC

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Laws HJ

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Buttlies B

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Kahn T

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Göbel U

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Burdach SE

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

31

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

56-60

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Activated T cells and cytokine-induced CD3+CD56+ killer cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Propagation of large numbers of T cells with natural killer cell markers

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199808%2931%3A2%3C56%3A%3AAID-MPO2%3E3.0.CO%3B2-Y

21 January 2018

Identifiers

10.1002/(SICI)1096-911X(199808)31:2<56::AID-MPO2>3.0.CO;2-Y

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9680927

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45888529&oldid=2088680745"